The DOI matches its Crossref record; 258 of the 258 references it cites were found in a registry or an index.
Protein transmission in neurodegenerative disease
Open accessAbstract
Most neurodegenerative diseases are characterized by the intracellular or extracellular aggregation of misfolded proteins such as amyloid-β and tau in Alzheimer disease, α-synuclein in Parkinson disease, and TAR DNA-binding protein 43 in amyotrophic lateral sclerosis. Accumulating evidence from both human studies and disease models indicates that intercellular transmission and the subsequent templated amplification of these misfolded proteins are involved in the onset and progression of various neurodegenerative diseases. The misfolded proteins that are transferred between cells are referred to as 'pathological seeds'. Recent studies have made exciting progress in identifying the characteristics of different pathological seeds, particularly those isolated from diseased brains. Advances have also been made in our understanding of the molecular mechanisms that regulate the transmission process, and the influence of the host cell on the conformation and properties of pathological seeds. The aim of this Review is to summarize our current knowledge of the cell-to-cell transmission of pathological proteins and to identify key questions for future investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The misfolded tau is then propagated through the cortex in a prion‐like fashion, leading to cellular failure and the development of cognitive deficits 140 .”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [140]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Masliah, E., Rockenstein, E. M., Mante, M., Crews, L. A., Spencer, B. J., Adame, A., Patrick, C., Trejo, M., Ubhi, K. K., Rohn, T. T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019338 · Cited by 422
RetractedNgolab, J., Trinh, I., Rockenstein, E., Mante, M., Florio, J., Trejo, M., Masliah, D., Adame, A., Masliah, E., & Rissman, R. A. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0445-5 · Cited by 200
RetractedRETRACTED ARTICLE: LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
Bae, E.-J., Kim, D.-K., Kim, C., Mante, M., Adame, A., Rockenstein, E., Ulusoy, A., Klinkenberg, M., Jeong, G. R., Bae, J. R., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05958-z · Cited by 149
RetractedSpencer, B. J., Valera, E., Rockenstein, E. M., Overk, C., Mante, M., Adame, A., Zago, W. M., Seubert, P. A., Barbour, R., Schenk, D., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0410-8 · Cited by 91
RetractedNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Cited by
Sorted by citations
Items 301–400 of 624
Zhao, Y., Dai, W.-J., & Liu, D. (2022) · Aging Clinical and Experimental Research · doi:10.1007/s40520-022-02211-y · Cited by 12
Brás, I. C., Khani, M. H., Vasili, E., Möbius, W., Riedel, D., Parfentev, I., Gerhardt, E., Fahlbusch, C., Urlaub, H., Zweckstetter, M., et al. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223516 · Cited by 18
Ramos, V., Reis, M. A., Ferreira, L., Silva, A. M., Ferraz, R., Vieira, M., Vasconcelos, V. M., & Martins, R. F. (2023) · Biomolecules · doi:10.3390/biom13101444 · Cited by 13
Preserving genome integrity: The vital role of SUMO-targeted ubiquitin ligases
Han, J., Mu, Y., & Huang, J. (2023) · Cell Insight · doi:10.1016/j.cellin.2023.100128 · Cited by 11
Synaptic Involvement of the Human Amygdala in Parkinson’s Disease
Villar‐Conde, S., Astillero‐Lopez, V., González-Rodríguez, M., Saiz‐Sánchez, D., Martı́nez-Marcos, A., Úbeda‐Bañón, I., & Flores‐Cuadrado, A. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100673 · Cited by 13
Invertebrate genetic models of amyotrophic lateral sclerosis
Zhou, L., & Xu, R. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1328578 · Cited by 12
Specific Binding of Alzheimer’s Aβ Peptides to Extracellular Vesicles
Coughlan, C. M., Lindenberger, J., Jacot, J. G., Johnson, N. R., Anton, P., Bevers, S., Welty, R., Graner, M., & Potter, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073703 · Cited by 12
Glycosaminoglycans in Neurodegenerative Diseases
Jin, W., Zhang, F., & Linhardt, R. J. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-70115-4_9 · Cited by 13
Santiago, A., & Morano, K. A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102424 · Cited by 13
RGMa collapses the neuronal actin barrier against disease-implicated protein and exacerbates ALS
Shimizu, M., Shiraishi, N., Tada, S., Sasaki, T., Beck, G., Nagano, S., Kinoshita, M., Sumi, H., Sugimoto, T., Ishida, Y., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg3193 · Cited by 12
The Multifaceted Role of Extracellular Vesicles in Alzheimer's Disease
Conceição, A. R., Marinatto, J., Pinheiro, L. S., Rody, T., & Felice, F. G. D. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70209 · Cited by 15
Visualizing liquid-liquid phase separation and protein aggregates
Xue, J., Cao, X.-W., Jia, X.-L., Chen, X., Guo, W., & Yin, D. (2025) · Communications Chemistry · doi:10.1038/s42004-025-01756-z · Cited by 15
α-Synuclein-dependent increases in PIP5K1γ drive inositol signaling to promote neurotoxicity
Horvath, J. D., Casas, M., Kutchukian, C., Sánchez, S. C., Pergande, M. R., Cologna, S. M., Simó, S., Dixon, R. E., & Dickson, E. J. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113244 · Cited by 11
The role of DNA damage in neural stem cells ageing
Zhong, Y., Wang, G., Yang, S., Zhang, Y., & Wang, X. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31187 · Cited by 12
Lee, E., Park, H., & Kim, S. (2024) · Molecules and Cells · doi:10.1016/j.mocell.2024.100089 · Cited by 12
Biosensors for Parkinson’s Disease: Where Are We Now, and Where Do We Need to Go?
Maddocks, G. M., Eisenstein, M. S., & Soh, H. T. (2024) · ACS Sensors · doi:10.1021/acssensors.4c00790 · Cited by 12
Gao, W. H., Dong, Q., Wu, X., Wang, Y., Li, J., Zhang, Q., Lu, F., & Liu, F. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00164 · Cited by 11
Esawii, H. A., Маматкулов, К. З., Mahran, H. A., Arzumanyan, G., & Mohamed, N. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140124 · Cited by 11
Advancements in extracellular vesicle therapy for neurodegenerative diseases
Hu, N., Chen, L., Hu, G., & Ma, R. (2025) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2025.1004104 · Cited by 12
Imbalanced mitochondrial dynamics in human PD and α-synuclein mouse brains
Brown, H. J., Fan, R. Z., Bell, R., Salehe, S. S., Gil, C. M., Lai, Y., & Tieu, K. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106976 · Cited by 16
Chemical probes for investigating protein liquid-liquid phase separation and aggregation
Sun, R., Zhang, S., Liu, Y., & Li, D. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102291 · Cited by 11
Ali, A., Masood, A., Khan, A. A., Zhu, F.-Y., Cheema, M. A. R., Samad, A., Wadood, A., Khan, A., Yu, Q., Heng, W., et al. (2023) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp06083c · Cited by 11
Multi target-directed imidazole derivatives for neurodegenerative diseases
Eliewi, A. G., Al‐Garawi, Z. S., Alkazzaz, F. F., & Atia, A. J. K. (2021) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1853/1/012066 · Cited by 11
4R-Tau seeding activity unravels molecular subtypes in patients with Progressive Supranuclear PalsyPreprint
Martínez-Valbuena, I., Lee, S., Santamaría, E., Fernández‐Irigoyen, J., Forrest, S. L., Li, J., Tanaka, H., Couto, B., Reyes, N. G. D., Qamar, S. H., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.28.559953 · Cited by 11
Insights into AlphaFold’s breakthrough in neurodegenerative diseases
Mubeen, H., Masood, A., Zafar, A., Khan, Z. Q., Khan, M. Q., & Nisa, A. U. (2024) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-024-03721-6 · Cited by 10
α-Synuclein fibrils enhance HIV-1 infection of human T cells, macrophages and microglia
Olari, L., Liu, S., Arnold, F., Kühlwein, J., Miró, M. G., Updahaya, A. R., Stürzel, C. M., Thal, D. R., Walther, P., Sparrer, K. M. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56099-z · Cited by 10
Satao, K. S., & Doshi, G. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123468 · Cited by 10
Raman spectroscopy and imaging of protein droplet formation and aggregation
Watson, M. D., & Lee, J. C. (2025) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2025.103041 · Cited by 10
DNA-based nanostructures for cell membrane receptor regulation and disease treatment
Cheng, Z., Liu, Y., Chen, Q., Man, Y., Man, Y., Zhang, Z., Du, S., Lv, Z., Wang, Q., Shao, K., et al. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115674 · Cited by 11
Keskin, I., Bidhendi, E. E., Marklund, M., Andersen, P. M., Brännström, T., Marklund, S. L., & Nordström, U. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01211-9 · Cited by 10
Neuroanatomical Tract Tracers: Not Just for Neural Tracing Anymore
Wang, W., Clark, J., & Mao, G. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00063 · Cited by 10
Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?
del Giudice, K. P., Cosgaya, M., Zaro, I., Ravasi, V., Santacruz, P., Painous, C., Fernández, M., Cámara, A., & Compta, Y. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.106080 · Cited by 10
Reclassifying neurodegenerative diseases
Villoslada, P., Baeza-Yates, R. A., & Masdeu, J. C. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0600-3 · Cited by 10
Rasmussen, J., Ewing, A. D., Bodea, L., Bodea, G. O., Gearing, M., & Faulkner, G. J. (2021) · Brain Pathology · doi:10.1111/bpa.13018 · Cited by 10
Rodin, S., Kozin, S. A., Kechko, O. I., Mitkevich, V. A., & Makarov, A. А. (2020) · Biochimie · doi:10.1016/j.biochi.2020.04.011 · Cited by 11
TDP-43 Amyloid Fibril Formation via Phase Separation-Related and -Unrelated Pathways
Lin, P., Wu, G.-W., Lin, Y., Huang, J.-R., Jeng, U., Liu, W.-M., & Huang, J. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00503 · Cited by 9
Yao, X., Cao, B., Liu, J., Lv, Q.-K., Zhang, J., Cheng, X., Mao, C., Ma, Q., Wang, F., & Liu, C. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70088 · Cited by 10
Salciccia, C., Costanzo, M., Ruocco, G., Porreca, F., Vivacqua, G., Fabbrini, G., Belvisi, D., Ladogana, A., & Poleggi, A. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105997 · Cited by 11
Zhang, S., Wang, L., Yi, S., Tsai, Y.-T., Cheng, Y.-H., Lin, Y.-T., Lin, C.-C., Lee, Y., Wang, H., Li, S., et al. (2025) · Autophagy · doi:10.1080/15548627.2024.2442858 · Cited by 10
Exploring exosome profiling via CytoFLEX Nano flow cytometer: Approaches and applications
Cao, L. K., Wang, H., Zhu, J., Li, W., Lin, H. L., Wang, Z., Wang, X., Guo, B., Ding, J., Tong, D., et al. (2025) · Open Research (University of Surrey) · doi:10.1002/viw.20250068 · Cited by 9
Wang, D., Clark, K. C., Rouen, K. C., Baird, G., Polackal, T. N., Kumar, P., Wyle, Y., Farmer, D. L., Carney, R. P., & Wang, A. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70175 · Cited by 13
Hydrophobic tagging: A promising paradigm for targeted protein degradation
Xin, L., Wang, H., Yang, M., Guo, Z., Zhu, M., Moore, T. W., Dong, C., & Zhou, H. (2025) · Cell Insight · doi:10.1016/j.cellin.2025.100295 · Cited by 10
Grahl, M. V. C., Andrade, B. D. S., Perin, A. P. A., Neves, G. A., Duarte, L. D. S., Uberti, A. F., Hohl, K. S., Follmer, C., & Carlini, C. R. (2023) · Microorganisms · doi:10.3390/microorganisms11082042 · Cited by 12
del Rı́o, J. A., & Ferrer, I. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.570692 · Cited by 8
Nguyen, D. L., Okolicsanyi, R. K., & Haupt, L. M. (2024) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2024.103936 · Cited by 9
Walkiewicz, G., Ronisz, A., Ospitalieri, S., Tsaka, G., Tomé, S. O., Vandenberghe, R. R., Arnim, C. A. F. V., Rousseau, F., Schymkowitz, J. W. H., Groef, L. D., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01907-8 · Cited by 8
α-Synuclein Degradation in Brain Pericytes Is Mediated via Akt, ERK, and p38 MAPK Signaling Pathways
Yokoya, M., Takata, F., Iwao, T., Matsumoto, J., Tanaka, Y., Aridome, H., Yasunaga, M., Mizoguchi, J., Sano, K., & Dohgu, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041615 · Cited by 10
Recent Trends in Hydrogel-Based Biosensor Technology for the Diagnosis of Neurodegenerative Diseases
Ayçiçek, S., Cevher, Ş. C., & Acar, S. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00420 · Cited by 9
The role of autophagy in synucleinopathy: clearance versus spread of α-synuclein
Birnbaum, E., & Yue, Z. (2025) · Autophagy Reports · doi:10.1080/27694127.2025.2577406 · Cited by 10
Genetically encoded fluorescent reporters to visualize α-synuclein pathology in live brain
Zhang, L. I., Yu, M., Chen, G., Ge, S., Wang, M., Zhang, X., Zhao, M., Gu, H., Huang, M., Liu, A., et al. (2026) · Cell · doi:10.1016/j.cell.2026.01.035 · Cited by 10
Cao, T., Li, X., Li, D., & Tao, Y. (2023) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2023.25 · Cited by 10
A Next-Generation Sequencing Study in a Cohort of Sicilian Patients with Parkinson’s Disease
Salemi, M., Lanza, G., Salluzzo, M. G., Schillaci, F. A., Blasi, F. D. D., Cordella, A., Caniglia, S., Lanuzza, B., Morreale, M., Marano, P., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11123118 · Cited by 10
Zhuang, C., Chen, B., Wu, S., Xu, L., Zhang, X., Zheng, X., Chen, Y., Geng, Y., Guan, J., Lin, Y., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00539 · Cited by 8
Moreira, R., Mendonça, L. S., & de Almeida, L. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212288 · Cited by 7
Characterizing the spatiotemporal variability of Alzheimer's disease pathologyPreprint
Vogel, J. W., Young, A., Oxtoby, N., Smith, R., Ossenkoppele, R., Strandberg, O., Joie, R. L., Aksman, L., Grothe, M., Iturria-Medina, Y., et al. (2020) · medRxiv · doi:10.1101/2020.08.20.20176883 · Cited by 10
Parkinson’s disease with hyposmia and dysautonomia: does it represent a distinct subtype?
Yoon, S. H., You, D. H., Na, H. K., Kang, S., Baik, K., Park, M., Lyoo, C. H., Sohn, Y. H., & Lee, P. H. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12332-1 · Cited by 7
Deng, J.-H., Zhang, H., Lan, X., Liu, Y., Liu, X.-L., Deng, H.-Z., Luo, S., Yao, G.-Z., Wu, H., Huang, B., et al. (2025) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000001720 · Cited by 7
Advances in clinical neurorestorative treatments of Parkinson's disease
Yin, Y., Su, D., Lam, J. S. T., & Feng, T. (2025) · Journal of Neurorestoratology · doi:10.1016/j.jnrt.2025.100204 · Cited by 8
PGRN as an emerging regulator of lipid metabolism in neurodegenerative diseases
Shi, Y., Hou, W., Li, B., & Zhu, C. (2025) · Communications Biology · doi:10.1038/s42003-025-08272-9 · Cited by 9
Design of Ig-like binders targeting α-synuclein fibril for mitigating its pathological activities
Zeng, S., Xiong, X., Long, H., Xu, Q., Yu, Y., Sun, B., Liu, C., Wang, Z., Xu, W., Zhang, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62755-1 · Cited by 7
Protein quality control systems in neurodegeneration – culprits, mitigators, and solutions?
Ciechanover, A. J., & Livneh, I. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1604076 · Cited by 8
An, W., Jin, Z., & Li, Y. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2025.1708655 · Cited by 8
Zhao, N., Zhang, Q., Yu, F., Yao, X., & Liu, H. (2023) · Biomolecules · doi:10.3390/biom13040682 · Cited by 7
Brown, K. A., Bender, S. J., & Johnson, A. L. (2023) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16969 · Cited by 7
Dinamarca, M. C., Colombo, L., Brykczynska, U., Grimm, A., Fruh, I., Hossain, I., Gabriel, D., Eckert, A., Müller, M. M., & Pecho‐Vrieseling, E. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1287510 · Cited by 7
Ding, D., Liang, X., Xiao, Z., Wu, W., Zhao, Q., & Cao, Y. (2020) · Brain and Behavior · doi:10.1002/brb3.1822 · Cited by 7
Therapeutic Potential of AAV1-Rheb(S16H) Transduction against Neurodegenerative Diseases
Nam, Y., Moon, G. J., & Kim, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063064 · Cited by 7
Clinical and Dopamine Depletion Patterns in Hyposmia- and Dysautonomia-Dominant Parkinson’s Disease
Yoo, H. S., Lee, S., Jeong, S. H., Ye, B. S., Sohn, Y. H., Yun, M., & Lee, P. H. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212747 · Cited by 7
Huelsmeier, J., Walker, E., Bakthavachalu, B., & Ramaswami, M. (2021) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkab355 · Cited by 10
Multiple roles of neuronal extracellular vesicles in neurological disorders
Jiao, Z., He, Z., Liu, N., Lai, Y., & Zhong, T. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.979856 · Cited by 7
Experimental models of gut‐first Parkinson's disease: A systematic review
Videlock, E. J., Xing, T., Yehya, A. H. S., & Travagli, R. A. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14604 · Cited by 9
Brás, I. C., Khani, M., Vasili, E., Möbius, W., Riedel, D., Parfentev, I., Gerhardt, E., Fahlbusch, C., Urlaub, H., Zweckstetter, M., et al. (2021) · bioRxiv · doi:10.1101/2021.07.18.452825 · Cited by 3
Singh, K., Gupta, J. K., Narayan, S., Rani, K., Jain, D., Porwal, P., Sharma, M. C., & Kumar, S. (2025) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010298545241108062449 · Cited by 6
Wang, Y., Chen, X., Zhang, C., & Gao, S. (2025) · Advanced Exercise and Health Science · doi:10.1016/j.aehs.2025.02.002 · Cited by 8
Murakami, K., Nguyen, T. H. V., Nagao, C., Mizuguchi, K., & Bitan, G. (2025) · JACS Au · doi:10.1021/jacsau.5c00269 · Cited by 6
Brain and retina in Alzheimer's disease: Pathological intersections and estimates from imaging
Banihashemi, M. A., Krance, S. H., Ji, P. X., Koo, M., Ottoy, J., Swartz, R. H., Kertes, P. J., Hudson, C., Goubran, M., & Black, S. E. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70884 · Cited by 7
Recent Advances in Proximity Labeling-Based Subcellular Proteomic Mapping
Wang, G., Liu, J., Sun, X., Qin, W., Han, S., & Zou, P. (2026) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2026.101520 · Cited by 6
LRP1: a novel receptor for the transmission of pathological α-Synuclein
Pan, C., & Peng, C. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00582-4 · Cited by 6
Self-citationTargeting Calpain-2 for Alzheimer’s Disease Treatment
Arnsten, A. F. T., & Baudry, M. (2023) · Medical Research Archives · doi:10.18103/mra.v11i2.3487 · Cited by 6
Revealing protein trafficking by proximity labeling-based proteomics
Wang, Y., & Qin, W. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.107041 · Cited by 6
Fang, X., Wu, F., & Jiang, C. (2023) · BMC Neurology · doi:10.1186/s12883-023-03224-4 · Cited by 6
Wang, H., Yin, X., Xu, J., Chen, L., Karuppagounder, S. S., Xu, E., Mao, X., Dawson, V. L., & Dawson, T. M. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.11.009 · Cited by 6
Xiao, Y., Spotorno, N., An, L., Bazinet, V., Hansen, J. Y., Strandberg, O. T., Shafiei, G., Behjat, H., Funck, T., Salvadó, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.17.648358 · Cited by 6
Factors responsible for alpha-Synuclein aggregation
Singh, K. S., Verma, R., Singh, N., Singh, L. R., & Gupta, A. (2025) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.11.004 · Cited by 7
Chiral Carbon Nanodots Modulate α‐Synuclein Homeostasis to Combat Parkinson's Disease
Han, Y., Zhang, Y., Huang, J., Jia, X., Ishibashi, T., & Jiang, X. (2025) · Small Methods · doi:10.1002/smtd.202500557 · Cited by 5
Li, Y., Torok, J., Zhang, S., Ding, J. L., Wang, N., Lau, C., Kulkarni, S., Anand, C., Tran, J., Cheng, M., et al. (2025) · Advanced Science · doi:10.1002/advs.202413052 · Cited by 5
Self-citationZhang, M., You, T., Guo, M., Zhao, Y., Shen, W., Jiang, Y., Jiang, Y., Dong, Q., Yu, J., Cui, M., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03838-5 · Cited by 7
Innovative Lipid-Based Nanobiotechnology: Diagnostics and Medicine
Seo, S. E., Kim, K. H., Singh, S., Chen, J.-S., Iijima, S., Cheng, C., Ryu, Y., Song, H. S., Li, W., & Kwon, O. S. (2026) · ACS Nano · doi:10.1021/acsnano.5c16718 · Cited by 5
Somatic mosaicism in ALS and FTD identifies focal mutations associated with widespread degeneration
Zhou, Z., Kim, J., Huang, A. Y., Nolan, M., Park, J., Doan, R. N., Shin, T., Miller, M. B., Bae, M., Zhao, B., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02570-6 · Cited by 9
Modeling human neurodegenerative disorders in Drosophila: strategies and translational opportunities
Mohamed, S. A., & Badr, O. A. M. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11844-5 · Cited by 5
Identification of Retinal Amyloid-Beta in Ex Vivo Human Glaucoma Eyes Using a Novel Ocular Tracer
Pilotte, J., Khoury, S., Tafreshi, A., Mandel, Z. T., Sharma, S. V., Vanderklish, P. W., Sarraf, S. T., Sadun, A. A., Weinreb, R. N., & Huang, A. S. (2024) · Journal of Glaucoma · doi:10.1097/ijg.0000000000002496 · Cited by 5
Matsuhisa, K., Sato, S., & Kaneko, M. (2025) · Biomedicines · doi:10.3390/biomedicines13040854 · Cited by 4
Abeta-induced presynaptic release of UBC9 through extracellular vesicles involves SNAP23
Long, Y., Cheng, Y., Yang, J., Yang, T., & Lai, Y. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136771 · Cited by 5
Understanding the Intricate Role of Exosomes in Pathogenesis of Alzheimer’s Disease
Chauhan, S., Behl, T., Sehgal, A., Singh, S., Sharma, N., Gupta, S., Albratty, M., Najmi, A., Meraya, A. M., & Alhazmi, H. A. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00621-4 · Cited by 6
Amyloid-like RIP1/RIP3 RHIM Fragments’ Characterization and Application as a Drug Depot
Ismail, M., & Kanapathipillai, M. (2023) · Molecules · doi:10.3390/molecules28031480 · Cited by 5
Extracellular Vesicles: The Invisible Heroes and Villains of COVID‐19 Central Neuropathology
Chang, H., Chen, E., Hu, Y., Wu, L., Deng, L., Ye, S., Mao, X., Zhu, T., Liu, J., & Chen, C. (2023) · Advanced Science · doi:10.1002/advs.202305554 · Cited by 4
LRP10 and α-synuclein transmission in Lewy body diseases
Mascaro, A. C., Grochowska, M. M., Boumeester, V., Dits, N. F. J., Bilgiҫ, E. N., Breedveld, G. J., Vergouw, L. J. M., de Jong, F. J., van Royen, M. E., Bonifati, V., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05135-0 · Cited by 6
Kon, T., Lee, S., Martínez-Valbuena, I., Yoshida, K., Tanikawa, S., Lang, A. E., & Kovács, G. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052676 · Cited by 5
Advancements in Single-Cell RNA Sequencing Research for Neurological Diseases
Yang, B., Hu, S., Jiang, Y., Xu, L., Shu, S., & Zhang, H. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04126-3 · Cited by 6
Differences in Tau Seeding in Newborn and Adult Wild-Type Mice
Ferrer, I., Andrés‐Benito, P., Garcia‐Esparcia, P., López‐González, I., Valiente, D., Jordán, M., Carmona, M., Sala‐Jarque, J., Gil, V., & del Rı́o, J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094789 · Cited by 5
Metadata
- Authors
- Peng, C., Trojanowski, J. Q., & Lee, V. M.-Y.
- Affiliations
- University of California, Los Angeles (US)
- University of Pennsylvania (US)
- Corresponding author
- Lee, Virginia M.-Y.
- Venue
- Nature Reviews Neurology
- Published
- 2020-03-23
- Volume
- 16
- Issue
- 4
- Pages
- 199-212
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- PMC
- PMC9242841
- OpenAlex
- W3012646333
- Cited by
- 625
- References
- 257
- Citations by year
- 2026: 73 · 2025: 106 · 2024: 116 · 2023: 99 · 2022: 92 · 2021: 100 · 2020: 39
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (U19AG062418)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- protein transmission, neurodegenerative diseases, protein aggregation, amyloid-beta, tau protein, alpha-synuclein, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, intercellular protein transfer
- MeSH terms
- Huntingtin Protein, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Axonal Transport, Brain, Cell Communication, DNA-Binding Proteins, Endocytosis, Humans, Huntington Disease, Membrane Fusion, Neuroglia, Neurons, Parkinson Disease, Amyloid beta-Peptides, tau Proteins, Neurodegenerative Diseases, Genetic Predisposition to Disease, Protein Transport, Nanotubes, alpha-Synuclein, Exosomes, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review